Deep Apple Therapeutics
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $52M
Investors
- 1
About Deep Apple Therapeutics
Based in New York, US, and founded in 2022 by co-founders Brian Shoichet and Georgios Skiniotis, Deep Apple Therapeutics, Inc. operates as a medical research-based company developing novel small molecules for many disease areas, including metabolic disorders, inflammation, immunology, and endocrine diseases. Deep Apple Therapeutics, Inc. provides a discovery engine that conducts virtual screens of vast, proprietary virtual libraries, comprising billions of compounds. This approach significantly cuts drug discovery time and enhances the probability of clinical and commercial success. The company specializes in small-molecule therapeutics. Deep Apple combines deep learning, cryo-EM-enabled structural biology, AI-powered pocket extraction, molecular dynamics, and ultra-high-volume virtual screening to rapidly identify and advance novel drug candidates. In addition, the firm’s technology is Orchard, a virtual library expansion tool that employs machine learning to accelerate hit discovery. The company's programs leverage the family of G-protein coupled receptors (GPCRs), addressing a variety of applications in diseases such as obesity, inflammation, and immunology.
Who invested in Deep Apple Therapeutics
1 investor across 1 round
See all investors in Deep Apple Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 14, 2023
Amount
$52M
Investors
Questions about Deep Apple Therapeutics
Who invested in Deep Apple Therapeutics?
Deep Apple Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Deep Apple Therapeutics raised?
Deep Apple Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Deep Apple Therapeutics last raise money?
Deep Apple Therapeutics's most recent round on record is a Series A, in Dec 2023.
What does Deep Apple Therapeutics do?
Based in New York, US, and founded in 2022 by co-founders Brian Shoichet and Georgios Skiniotis, Deep Apple Therapeutics, Inc.
Where is Deep Apple Therapeutics headquartered?
Deep Apple Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Deep Apple Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Deep Apple Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Deep Apple Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.